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Streptococcus pneumoniae undergoes spontaneous phase variation resulting in opaque and transparent
colony forms. Differences in colony opacity correlate with differences in virulence: the transparent variants are
more capable of colonizing the nasopharynx, whereas the opaque variants show increased virulence during
systemic infections. To gain insight into the pathogenesis of pneumococcal disease at the molecular level,
protein expression patterns of the phenotypic variants of two pneumococcal strains were compared by high-
resolution two-dimensional protein electrophoresis. In comparison with transparent variants, the opaque
variants reduced the expression of two proteins and overexpressed one protein. The proteins were identified by
mass spectrometric analysis. The protein overexpressed in the opaque phenotype revealed significant homology
to elongation factor Ts of Helicobacter pylori. One of the two proteins that were underexpressed in the opaque
variants revealed significant homology to the proteinase maturation protein PrtM of Lactocobacillus paracasei,
a member of the family of peptidyl-prolyl cis/trans isomerases. A consensus lipoprotein signal sequence
suggests that the putative proteinase maturation protein A, designated PpmA, is located at the surface of the
pneumococcus and may play a role in the maturation of surface or secreted proteins. The second underex-
pressed protein was identified as pyruvate oxidase, SpxB. The lower SpxB expression in opaque variants most
probably explains the reduced production of hydrogen peroxide, a reaction product of SpxB, in this variant.
Since a spxB-defective pneumococcal mutant has decreased ability to colonize the nasopharynx (B. Spellerberg,
D. R. Cundell, J. Sandros, B. J. Pearce, I. Idanpaan-Heikkila, C. Rosenow, and H. R. Masure, 1996. Mol.
Microbiol. 19:803–813, 1996), our data suggest that SpxB plays an important role in enhancing the ability of
transparent variants to efficiently colonize the nasopharynx.
A critical process in the pathogenesis of infections caused by
Streptococcus pneumoniae is the ability of the pathogen to
adapt to various ecological niches in the human host. The
pneumococcus colonizes the human nasopharynx and may
spread locally to cause upper and lower respiratory tract in-
fection. In some cases, pneumococci are able to enter the
bloodstream and cause bacteremia or cross the blood-brain
barrier and cause meningitis.
As is the case for other respiratory tract pathogens that
frequently cause invasive infection, the ability to survive in
these different host environments requires the regulation of
the synthesis of key surface structures (10, 31). In S. pneu-
moniae, the reversible expression or phase variation in struc-
tures can be detected as spontaneous, reversible changes in
colony morphology. Differences in surface molecules affect the
arrangement of organisms within a colony, resulting in a
change in colony appearance (32). The frequency of switching
in colony morphology is highly variable from isolate to isolate
and appears to be independent of in vitro growth conditions
including pH, temperature, and osmolarity (32). Genetic anal-
ysis has demonstrated that a stem-loop-forming repetitive el-
ement, BOX A-C, located upstream of the glpF gene, increases
the variation in opacity (23).
Differences in colony morphology correlate with differences
in in vitro and in vivo characteristics. In an infant-rat model of
nasopharyngeal carriage, only the transparent phenotype is
able to establish dense and stable colonization of the mucosal
surface of the nasopharynx (32). This can be explained by the
enhanced binding of transparent pneumococci to buccal epi-
thelial cells and their glycoconjugate receptors when compared
to opaque pneumococci (5). Similarly, the adherence of trans-
parent pneumococci to cytokine-stimulated human type II lung
cells and human vascular endothelial cells is enhanced, as well
as the receptors (N-acetyl-D-glucosamine and platelet-activat-
ing factor [PAF] receptor) that appear on these cells after
cytokine stimulation (5). On the other hand, the opaque vari-
ant is more virulent in an animal model of systemic infection
following intraperitoneal inoculation of adult mice (13). The
higher virulence of the opaque variant in an in vivo model of
sepsis correlates with decreased opsonophagocytic killing of
opaque pneumococci in the in vitro phagocytosis assay (12).
Finally, the transparent variants have an increased capacity to
cross the blood-brain barrier (20). The higher binding affinity
of transparent pneumococci to the PAF receptor on microvas-
cular endothelial cells is suggested to result in increased trans-
cytosis of bacteria across these cells.
To gain insight in the pathogenesis of pneumococcal disease
at a molecular level, the relationship between several previ-
ously identified cell surface structures and opacity variation has
been examined. The opaque phenotype is associated with
larger amounts of capsular polysaccharide than is the trans-
parent phenotype (12, 13). In contrast, the transparent pheno-
type produces increased amounts of teichoic acid, which con-
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tains phosphorylcholine (13, 30). Phosphorylcholine forms an
anchor for at least eight choline-binding proteins (21). This
structure is also part of PAF and is suggested to be important
in the attachment to cytokine-activated human cells via the
PAF receptor by structural mimicry (5). Differences in the
amount of phosphorylcholine might explain the switch be-
tween adherent and nonadherent phenotypes. Phenotypic vari-
ation also correlates with differential expression of cell surface
proteins, including three choline-binding proteins, LytA, PspA
and CbpA. Opaque variants undergo spontaneous lysis more
slowly as a result of the decreased expression of the major
amidase, LytA (33). In contrast to LytA, PspA is expressed in
greater amounts in the opaque variant (13). PspA inhibits
complement activation, thereby reducing the effectiveness of
complement receptor-mediated pathways of clearance (27). In
addition, PspA binds lactoferrin, an iron-sequestering glyco-
protein that predominates in mucosal secretions, and may
function in iron acquisition at mucosal surfaces (9). The dif-
ferential expression of CbpA is similar to that of LytA, such
that transparent variants express increased amounts of this
protein (21). CbpA mediates adherence to cytokine-activated
human lung epithelial and endothelial cells, is involved in in-
vasion through microvascular endothelial cells, and partici-
pates in pneumococcal colonization of the nasopharynx (20,
21). The expression levels of LytA, PspA, and CbpA are un-
likely to determine colony morphology directly, since mutants
lacking each of the encoding genes still undergo variation in
colony morphology (13, 21, 30).
The purpose of this study was to identify additional proteins
that are differentially expressed in the phenotypic variants of S.
pneumoniae to gain insight into the molecular changes that
occur during phase variation. This information will contribute
to an improved understanding of the molecular adaptation of
phenotypic variants of pneumococci that result in changes in
virulence and colony morphology. This paper reports on a
comparison of expression patterns of the phenotypic variants
of two pneumococcal strains by high-resolution two-dimen-
sional protein electrophoresis and the identification of differ-
entially expressed proteins by mass spectrometry.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and growth medium. Bacteria were re-
moved from storage at 270°C and cultured at 37°C on Columbia agar supple-
mented with 5% defibrinated sheep blood (Oxoid, Basingstoke, United King-
dom) in an atmosphere of increased CO2. Bacterial colonies were inoculated in
Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.) supplemented with
0.5% yeast extract (Difco Laboratories) (THY broth) and grown at 37°C. Broth
cultures were plated onto THY agar plates (15 g of agar per liter) impregnated
with 80 U of catalase (Worthington Biochemical, Freehold, N.J.) per cm2 and
incubated at 37°C in an atmosphere of increased CO2 that was provided in a
candle extinction jar. Colony morphology of all cultures was determined as
described previously (32). The pneumococcal strains used in this study are the
opaque and transparent variants of type 9V clinical isolate p10 (32) and the
opaque and transparent variants of type 6B clinical isolate p314 (12). S. pneu-
moniae D39 (2) and a spxB-defective mutant (D39; spxB::pHRM104, phoA1
[26]) were used as control strains used in the hydrogen peroxide assay. A ppmA-
defective mutant (D39; ppmA::ermAM (16a) was used as a control strain used for
Western blot analysis.
Protein sample preparation. The bacteria were cultured overnight in 10 ml of
THY broth and subsequently to logarithmic growth phase (optical density at 550
nm 5 0.3) in 250 ml of THY broth. This culture was harvested by centrifugation
(1,500 3 g for 15 min) and washed twice with 250 ml of phosphate-buffered saline
(pH 7.5) and once with 10 ml of Tris-EDTA buffer (10 mM Tris-HCl, 1 mM
EDTA). The cells were disrupted by ultrasonic treatment (15 min with a microtip
in a model 250 sonifier [Branson Ultrasonics, Danbury, Conn.]) while being held
at 5°C. Protein concentrations were determined by the method of Bradford (3).
Two-dimensional protein gel electrophoresis, staining, and computerized
comparison of the protein profiles. Isoelectric focusing (pI 4 to 7) was performed
with a Multiphor II electrophoresis unit and Immobiline DryStrips (Pharmacia
Biotech, Uppsala, Sweden) as recommended by the manufacturers and with the
modifications described by Rabilloud et al. (18). The proteins were separated in
the second dimension by gradient (12 to 20% polyacrylamide) polyacrylamide gel
electrophoresis. Bacterial lysates containing 300 mg of protein were analyzed in
the individual experiments. Polyacrylamide gels were stained with Coomassie
brilliant blue (CBB) (24). The software program PD Quest (PDI, New York,
N.Y.) was used for the computerized analysis of two-dimensional protein pro-
files. The relative amount of a protein, represented in parts per million (ppm),
was determined by dividing the spot quantity by the total density of all proteins
in the gel, thereby normalizing the amount of a single protein to the total amount
of protein loaded. Significant differences in protein expression levels in the
phenotypic variants were determined by the Mann-Whitney test with a set value
of P # 0.05.
Purification, tryptic digest and mass spectrometric analysis of the proteins.
The protein gel spots of interest were excised from the gel. The gel fragments
were sliced thinly and washed twice for 15 min in 5% trichloroacetic acid
(CCl3COOH [Merck, Darmstadt, Germany]) and three times in distilled water.
The gel fragments were equilibrated in sample buffer (pH 6.8) (0.1% sodium
dodecyl sulfate [SDS], 10% glycerol, 50 mM dithiothreitol, 12 mM Tris-HCl,
0.01% bromophenol blue indicator [Merck]) for 1 h at room temperature. The
proteins were concentrated by an agarose electrophoresis (1% agarose type VIII
[Sigma, St. Louis, Mo.]) method as described by Rider et al. (19) and Gevaert et
al. (7) on a model 150-A gel electrophoresis cell (Bio-Rad Laboratories, Rich-
mond, Calif.) with Pasteur pipettes. The agarose gel was stained with carconcar-
boxylic acid (Sigma), and the proteins were excised from the gel. The agarose
fragments were washed with distilled water, and resuspended in 18 ml of diges-
tion buffer (pH 8.0) (50 mM NH4HCO3, 5 mM CaCl2). The agarose was melted
at 85°C for 1 min. After it was cooled to 37°C, 0.05 mg of trypsin (trypsin modified
sequencing grade [Promega, Madison, Wis.]) per ml was added for at least 15 h
at 37°C to digest the proteins. Trypsin was inactivated by adding 1 ml of 10%
trifluoroacetic acid CF3COOH [Merck]). The tryptic digests were analyzed using
a reversed-phase microcapillary column-switching high-pressure liquid chroma-
tography system (16, 28). Peptide sequencing was performed on an LCQ quad-
rupole ion trap mass spectrometer (Finnigan MAT, San Jose, Calif.). Tandem
mass spectrometric data were collected in data-dependent scan mode for se-
quence information on single tryptic digest products. With Peptide Search (14),
the deduced (partial) amino acid sequences were analyzed for matching se-
quences in all possible translation products of the most current version of the
unfinished pneumococcal genome released by The Institute for Genomic Re-
search (TIGR) (http://www.tigr.org/data/s_pneumoniae/) to identify the proteins.
With the BLAST algorithm (1), putative pneumococcal proteins were analyzed
for similarity to sequences deposited in the November 1999 version of the
nonredundant protein database at the National Center for Biotechnology Infor-
mation (Washington, D.C.).
Hydrogen peroxide assay. Hydrogen peroxide production by pneumococci was
determined by the method of Pick and Keisari (17) and modified by Duane et al.
(6). Bacteria were grown to mid-log phase, washed, and then grown in 250 ml of
brain heart infusion broth (BBL Microbiology Systems, Cockeysville, Md.) in
96-well plates. Negative control wells contained 1,000 U of catalase per ml. After
1 h of incubation at 37°C, the cultures were harvested and centrifuged at
10,000 3 g for 2 min and the supernatant was filtered through 0.2-mm-pore-size
filters. Phenol red and horseradish peroxidase were added to the assay buffer (5.0
mM K2HPO4, 1.0 mM KH2PO4, 140 mM NaCl, 0.5 mM glucose [pH 7.4]) at a
final concentration of 0.46 mM and 0.046 U/ml, respectively, and the buffer was
immediately used in the assay. Duplicate 250-ml aliquots of filtered supernatant
were then mixed with 1.05 ml of assay mixture and incubated for 30 min at 37°C.
The reactions were stopped by the addition of 5.0 ml of 1.0 N NaOH. The optical
density was recorded at 610 nm. Concentrations were calculated from a standard
curve generated for each assay by adding known dilutions of 30% H2O2 to 250-ml
aliquots of control supernatant. Control supernatant was heated to 100°C for 20
min before addition of H2O2 to eliminate catalase activity. Finally, the optical
density of the culture as well as the number of CFU per milliliter was deter-
mined.
Western blot analysis. One-dimensional SDS polyacrylamide gel electro-
phoresis was carried out in the Bio-Rad minigel system with 13% polyacrylamide
gels. Bacterial lysates (0.5 mg) were dissolved in sample buffer (10 mM Tris-HCl,
1 mM EDTA, 1% SDS, 10 mM dithiothreitol, 10% glycerol, 0.01% bromophenol
blue), boiled for 5 min, and subjected to electrophoresis (24). The proteins in the
gel were transferred to Immobilon-P membranes (Millipore Corp., Bedford,
Mass.) as described by Sambrook et al. (24). The membranes were washed twice
for 10 min each with Tris-HCl-buffered saline (pH 7.5) supplemented with 0.05%
Tween 20 (TBSt). The membranes were incubated with 2% bovine serum albu-
min for 1 h at room temperature, washed twice for 10 min each with TBSt, and
incubated with 1:10,000-diluted anti-PpmA rabbit serum (Overweg et al., sub-
mitted) for at least 2 h with constant stirring. After the washing step, 1:4,000-
diluted anti-rabbit immunoglobulin-alkaline phosphatase conjugate (Sigma) was
added. After 1 h, the membranes were washed in TBSt and then in alkaline
phosphatase buffer (100 mM Tris-HCl [pH 9.5], 100 mM NaCl, 5 mM MgCl2).
The blots were incubated with 0.33 mg of nitroblue tetrazolium (Sigma) per ml
and 0.17 mg of 5-bromo-4-chloro-3-indolylphosphate (Sigma) per ml in alkaline
phosphatase buffer in the dark. The staining reaction was stopped with distilled
water.
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RESULTS
Differentially expressed proteins in phenotypic variants of
S. pneumoniae. The relative protein expression levels of phe-
notypic variants of strain p10 with opaque and transparent
colony morphologies were compared using two-dimensional
protein gel electrophoresis followed by computerized compar-
ison of the CBB-stained gels. We performed this experiment
with four cultures of opaque pneumococci and four cultures of
transparent pneumococci. Approximately 200 distinct protein
spots were analyzed. The quantity of two proteins, designated
proteins 1 and 2, was decreased and the expression of protein
3 was increased in the opaque variant (Fig. 1). Protein 1 (65
kDa; pI, 5.4) was clearly detectable in the CBB-stained protein
expression profile of the transparent variant but was not de-
tectable in the opaque variant (Fig. 2). The quantity of protein
2 (35 kDa; pI, 5.0) in the transparent variant was 2.6 times the
quantity of this protein in the opaque variant. In contrast, the
quantity of protein 3 (40 kDa; pI, 5.1) was 2.1-fold greater in
the opaque variant. The differences in the expression of pro-
teins 1, 2, and 3 in the pneumococcal variants were statistically
significant. The amounts of proteins 1, 2, and 3 were also
compared in the phenotypic variants of clinical isolate strain
p314 (serotype 6B). Again, proteins 1 and 2 were more prev-
alent in the transparent phenotype and protein 3 was more
prevalent in the opaque phenotype; the levels of protein 1 and
2 were 1.3 times higher in the transparent variant and that of
protein 3 was 1.4 times higher in the opaque variant. Although
the relative expression levels of all three proteins were less
pronounced in the p314 variants, the trend in the differential
expression of the proteins is comparable between strains p10
and p314 (Fig. 2).
The expression of pyruvate oxidase is increased in trans-
parent pneumococcal variants. Tryptic digestion products of
protein 1 were analyzed by mass spectrometry. Nine amino
acid sequences were identical to the amino acid sequence of
the pneumococcal pyruvate oxidase, SpxB, except for leucine
389, which was reported as a serine by Spellerberg et al. (26)
(GenBank accession number L39074) and as an asparagine by
TIGR (Fig. 3). Since Spellerberg et al. analyzed the nucleotide
sequence of spxB of strain R6x (26) and TIGR sequenced the
genome of a type 4 pneumococcal strain, this discrepancy may
be a strain-specific difference. The calculated SpxB molecular
mass of 65,183 kDa correlated with the molecular ratio deter-
mined from two-dimensional protein electrophoresis, support-
ing the identity of the protein.
Since SpxB activity is known to result in the production of
H2O2 (26), we measured H2O2 production in the phenotypic
variants of strain p10. Opaque pneumococci produced ,0.1
mmol of H2O2 per liter in 1 h, which is the detection limit of
the assay, whereas transparent pneumococci produced 0.6
mmol of H2O2 per liter in the same period (5 3 10
4 CFU/ml).
In controls, strain D39 generated 0.45 mmol of H2O2 per liter
under similar conditions and the SpxB mutant of D39 pro-
duced ,0.1 nmol of H2O2 per liter. The higher production of
H2O2 by the transparent variant correlates with the difference
in the amount of protein observed by comparison of protein
expression patterns.
Increased expression of a proteinase maturation protein
homologue in transparent pneumococcal variants. Mass spec-
trometric analysis of protein 2 resulted in seven peptides that
were all identical to a putative translation product from the
TIGR pneumococcal genome except for amino acid 142 (Fig.
4). This Tyr142-to-Gln/Lys substitution is most probably the
result of strain-specific differences, since TIGR sequenced the
genome of a type 4 pneumococcal strain. Since glutamine and
lysine have the same residue mass, it is not possible to distin-
guish between them by mass spectrometry. The open reading
frame encoding a hypothetical protein of 322 amino acids is
located at nucleotides 7632 to 8597 on contig 33 of the TIGR
sequence. The calculated molecular mass of this protein (35.4
kDa) is similar to the molecular ratio of protein 2 (35 kDa)
identified by two-dimensional protein electrophoresis, sup-
FIG. 1. Two-dimensional analysis of the cellular proteins of the opaque (A) and transparent (B) variants of pneumococcal clinical isolate p10. Bacterial proteins
were separated by isoelectric focusing (pI 4 to 7) and gradient SDS-polyacrylamide gel electrophoresis (20 to 90 kDa). Circles and squares mark proteins with decreased
and increased expression in the transparent variant, respectively, compared to the opaque variant. 1, 2, and 3 refer to the proteins discussed in the text.
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porting the identity of the protein. We designated this pneu-
mococcal protein PpmA (for “putative proteinase matura-
tion protein A”) because it showed significant homology to
the proteinase maturation protein (PrtM) of Lactobacillus
paracasei (SWISS-PROT accession number Q02473) (Fig.
4). PrtM is essential for the production of active forms of the
serine protease PrtP (8, 29). In L. paracasei, the gene en-
coding PrtP is located immediately downstream of prtM
(11). In S. pneumoniae, no open reading frame homologous
to serine proteases is found downstream of ppmA. PrtM is a
membrane-bound lipoprotein in lactic acid bacteria (8).
Also, ppmA contains a signal sequence of bacterial lipopro-
teins (Fig. 4).
Differences in the amount of PpmA in the phenotypic vari-
ants were also demonstrated by Western blot analysis. Whole-
cell lysates from a ppmA-negative mutant and its parent strain
demonstrated the PpmA band position (Fig. 5, lanes 1 and 2).
When equivalent amounts of bacterial lysates of phenotypic
variants of strains p10 and p314 were compared on Western
blots, the amount of PpmA was larger in the transparent vari-
ants (lanes 4 and 6).
Reduced production of a putative elongation factor Ts in
transparent pneumococcal variants. Mass spectrometric anal-
ysis of tryptic digestion products of protein 3 revealed three
peptide sequences that were identical to a putative translation
product from the TIGR pneumococcal genome (Fig. 6). The
open reading frame encoding a hypothetical protein of 359
amino acids is located at nucleotides 911 to 1987 on contig 50
of S. pneumoniae. The calculated molecular mass (38.9 kDa)
correlates with the molecular ratio of protein 3 (40 kDa) de-
termined by two-dimensional protein electrophoresis. This
protein showed significant homology to elongation factor Ts
(EF-Ts) of Helicobacter pylori J99 (SWISS-PROT accession
number AE001567) (Fig. 6).
FIG. 2. Relative expression levels of proteins 1, 2, and 3 as repeatedly observed in four independent experiments with the opaque variant (solid bars) and the
transparent variant (open bars) of pneumococcal clinical isolate p10 (serotype 9V) and observed in a single experiment with clinical isolate p314 (serotype 6B). Asterisks
depict significant difference (P # 0.05) in the relative protein quantity in the opaque and transparent variants.
FIG. 3. Amino acid sequence of the pneumococcal pyruvate oxidase (GenBank accession number L39074). The amino acid sequences of protein 1 derived by mass
spectrometric analysis are depicted bold and underlined.
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DISCUSSION
Phenotypic variation is an important mechanism that allows
bacterial pathogens to adapt to different host environments.
The ability to survive in different host environments is the
result of molecular adaptation, e.g., changes in the expression
of specific cell surface components (10, 31). The expression of
four previously identified proteins has been examined in phase
variants of S. pneumoniae. PspA is expressed in larger amounts
in the opaque phenotype, whereas CbpA and LytA are ex-
pressed in larger amounts in the transparent phenotype (13,
21, 33). No difference in pneumolysin expression has been
found by Western blot analysis of whole-cell lysates of the
opaque and transparent variants (13). In this study, we iden-
tified and characterized three additional proteins that are dif-
ferentially expressed in phenotypic variants of S. pneumoniae.
The minimal protein amount necessary for detection and iden-
tification by mass spectrometric analysis is about 500 fmol. For
this reason, gels were stained with CBB and not by the more
sensitive silver-stain method, since only proteins visualized by
CBB staining reached the mass spectrometry analysis detection
level. This may explain why we did not confirm the differential
expression of LytA, PspA, and CbpA in the phenotypic vari-
ants and why we identified differential expression of three
proteins only.
We demonstrated that the expression of pyruvate oxidase
was increased in the transparent variants. Pyruvate oxidases
are crucial for aerobic carbohydrate metabolism of several
streptococci (4). This enzyme decarboxylates pyruvate to acetyl
phosphate, resulting in the release of H2O2 and CO2. In S.
pneumoniae, the release of H2O2 is mainly the result of SpxB
activity, since a spxB-defective mutant produces virtually no
H2O2 in comparison with the parent strain (26). Therefore, the
higher expression of SpxB in the transparent phenotype most
probably explains the increased production of hydrogen per-
oxide. Spellerberg et al. have identified pyruvate oxidase as an
indirect determinant of virulence in S. pneumoniae (26). A
spxB mutant has a decreased ability to colonize the nasophar-
ynx in a rabbit model. This is reflected by the lower capacity of
binding to the nasopharyngeal cells and to their glycoconjugate
receptors. The decreased ability of spxB-defective pneumococ-
cal mutants to colonize the nasopharynx and the increased
expression of SpxB in transparent variants suggests the poten-
tially important role of SpxB in efficient colonization of the
nasopharynx by transparent variants (26). The expression level
of SpxB is unlikely to directly determine colony morphology,
since the spxB mutant of D39 still varies in colony morphology
(J. N. Weiser, unpublished data).
The second protein with increased expression in the trans-
parent variant demonstrated significant sequence homology to
FIG. 4. The hypothetical pneumococcal protein encoded by nucleotides 7632 to 8597 on contig 33 of the TIGR pneumococcal genome (protein 2) displays 41%
sequence similarity to the proteinase maturation protein (PrtM) of L. paracasei (SWISS-PROT accession number Q02473). The putative lipoprotein signal sequence
is underlined. The amino acid sequences of protein 2 derived by mass spectrometric analysis are depicted in bold.
FIG. 5. Western blot analysis of phenotypic variants with anti-PpmA rabbit
serum. The amount of PpmA was compared in equivalent amounts of whole-cell
lysates of opaque (lanes 3 and 5) and transparent (lanes 4 and 6) variants of
pneumococcal clinical isolate p10 (lanes 3 and 4) and p314 (lanes 5 and 6). The
ppmA-deficient mutant (lane 2) and its parent strain D39 (lane 1) were used as
controls. Numbers indicate the molecular size markers (in kilodaltons). The
arrow indicates the PpmA protein band.
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proteinase maturation protein (PrtM) of L. paracasei. L. para-
casei and other lactic acid bacteria are used in the food indus-
try for the production of a variety of fermented milk products.
During growth, these bacteria produce cell envelope-located
serine proteases that break down caseins, the major proteins in
milk. PrtM is a trans-acting protein involved in the maturation
(processing into active proteins) of serine protease, PrtP (29).
PrtM belongs to the family of peptidyl-prolyl cis/trans isomer-
ases that are thought to assist in protein folding by catalyzing
the cis-trans isomerization of the peptidyl-prolyl bonds in pep-
tides and proteins (22). PpmA contains an N-terminal lipopro-
tein signal sequence, which suggests that PpmA, like PrtM (8),
is membrane bound. We hypothesize that PpmA also functions
as a membrane-bound molecular chaperone. In L. paracasei,
the gene encoding PrtP is located immediately downstream of
prtM (11). Both prtM and prtP were found to be transcribed
from the same promoter region but in opposite directions (29).
In S. pneumoniae, no open reading frame homologous to a
serine protease could be located in the direct vicinity of ppmA.
The pneumococcal proteins activated by PpmA are currently
unknown. We demonstrated differential expression of PpmA
in the phenotypic variants of S. pneumoniae, which suggests
that PpmA may play a role in the pathogenesis of infections.
PpmA is more prevalent in the transparent phenotype that is
selected for during nasopharyngeal colonization, suggesting
that PpmA is directly involved in adherence through matura-
tion of surface proteins with adherence properties or indirectly
by the activation of proteases or other secreted proteins.
The expression of the third protein, identified as EF-Ts, was
increased in the opaque phenotype. EF-Ts is essential for the
elongation of the polypeptide chain during protein synthesis.
The protein mediates the regeneration of EF-Tu z GDP into
the active form, EF-Tu z GTP. This active form of EF-Tu
facilitates the entry of aminoacyl-tRNA to the ribosome, en-
abling protein synthesis. Differential expression of EF-Ts has
been found previously in the gram-negative bacterium Coxiella
burnetii (25), the causative agent of Q fever. This obligate
intracellular parasite replicates in distinct morphological forms
that may allow potential life cycle variants to survive the harsh
environment of the phagolysosome. Two distinct morphologi-
cal forms of C. burnetii have been described, a large-cell variant
and a small-cell variant. Large-cell variants are metabolically
more active than small-cell variants (15). This is supported by
data showing that EF-Ts and EF-Tu were more prevalent in
large-cell variants (25). We hypothesize that the increased
presence of EF-Ts in the opaque variants of S. pneumoniae
indicates that, like in C. burnetii, the opaque variants are met-
abolically more active, which may explain the rapid invasive
growth characteristics of these variants.
This study shows that the combination of two-dimensional
protein gel electrophoresis, mass spectrometry, and genomics
is a powerful tool for the identification of differentially ex-
pressed proteins in phenotypic variants of S. pneumoniae. We
have identified differential expression of pyruvate oxidase, a
new member of the family of peptidyl-prolyl cis/trans isomer-
ases (PpmA), and EF-Ts in pneumococcal phenotypic variants
of type 9V and 6B clinical isolates. We hypothesize that the
higher expression of both pyruvate oxidase and PpmA in the
transparent phenotype correlates with increased adhesive
properties and ability to colonize the nasopharynx. The higher
expression of EF-Ts in the opaque variant might indicate a
higher metabolic activity.
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FIG. 6. The hypothetical pneumococcal protein encoded by nucleotides 911 to 1987 on contig 50 of the TIGR pneumococcal genome (protein 3) displays 61%
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